ABSTRACT
INTRODUCTION
second requirement for the new molecular target should be its absence in the human host.
Flavodoxins have been identified in both prokaryotes [25] and eukaryotes [26] but not in mammals, where flavodoxin-like domains are found as part of larger proteins such as P450 reductase [27] . Besides, the flavodoxin has been proposed to play a potencial role in the pathogenesis of MALT lymphoma, being detected in the sera of a high percentage of patients with MALToma compared to patients with other diseases related with H. pylori [28] .
Flavodoxin thus, seems a promising candidate to be a target to develop drugs suited for the eradication of the bacterium.
Our laboratory has used over the years the flavodoxin from a different specie (Anabaena PCC7119) as a model protein to investigate protein stability, protein folding and binding [29] [30] [31] [32] [33] [34] [35] . From the structural point of view, flavodoxins are α/β proteins and bind, at the C-terminal end of the β-sheet, a molecule of flavin mononucleotide (FMN) that confers redox properties to the protein [36] . The redox potentials of FMN are drastically altered by the protein environment, making possible the one-electron reduction of the cofactor, which is essential for protein function. The different flavodoxins are usually classified in two groups:
short-chain flavodoxin (with around 150 residues) and long-chain flavodoxin (with an insertion of 20 residues in the fifth strand of the β-sheet [37] ). H. pylori flavodoxin belongs to the long-chain group, like that from Anabaena. The two proteins share a 43% sequence identity (Fig. 1a) . Although the overall fold of H. pylori flavodoxin is similar to that of other known flavodoxin, its FMN binding site is peculiar (Fig. 1b) because it contains, in one of the cofactor binding loops, an alanine residue where a vast majority of flavodoxins display an aromatic residue, typically a tryptophan. This makes the FMN of H. pylori flavodoxin partly accessible to solvent through a pocket at the protein surface where small molecules could bind and inhibit protein function, and thus, bacterium growth. The inhibitory effect could be exerted either by modifying the environment of the FMN and thus, altering the redox potentials [38] or simply, if the ligand is bulky enough, by interfering with flavodoxin recognition by the POR partner complex. We begin here, exploring this possibility by testing the binding of small molecules to the pocket near the FMN binding site in H. pylori flavodoxin.
EXPERIMENTAL DNA isolation, and PCR amplification of the fldA gene
Total genomic DNA was isolated from three different H. pylori antigen-positive stool samples and three negative matched controls using QIAamp DNA Stool Mini Kit (Qiagen).
H. pylori antigen status was ascertained by ELISA, using Premier Platinum Stool Antigen detection test HpSA, and by immunochromatography using Immunocard STAT HpSA (Meridian Diagnostics, Inc.). Then, the H. pylori flavodoxin DNA coding sequence was amplified by PCR, using the Nco-5´Primer: GGATTGAGCATATGGGAAAAATTGG and the BamHI 3´primer: CTAACAATGAAGGATCCAATTCTAG. Both primers were derived from the directly submitted J99 fldA sequence (accession number AF221524 [39] ) obtained from the Genebank (EMBL) database. The reaction mixture (50µl) contained undigested chromosomal DNA, 1 µg; primers, 50 ng; dNTP mixture, 2 mM; 10-fold-concentrated amplification buffer, 5 µl and Taq DNA polymerase (Madgen), 1.5 units. Thirty-five cycles of Recombinant overexpression and purification of H. pylori flavodoxin E. coli expression strain BL21 containing the pET28a-fldA plasmid was grown in 10 ml of Luria-Bertani medium in the presence of 0.2 mg kanamycine. The culture was diluted 10-fold in the same conditions and cells were grown to an absorbance of 0.8 at 600 nm. At this point, isopropyl β-D-thiogalactoside (IPTG) was added to a final concentration of 1mM and the cells were allowed to grow for at least 3 h and then pelleted and washed once with 0.15 M NaCl. After centrifugation, the cells were dissolved in 50 mM Tris-HCl buffer, pH 8, In addition, the Anabaena flavodoxin W57A mutant, where the highly conserved tryptophan residue of the FMN binding site is substituted by alanine, was expressed and purified as described [30] .
Determination of extinction coefficients
The extinction coefficient of H. pylori flavodoxin in the fully oxidized state was determined as described by Mayhew and Massey [40] were recorded, with excitation at 280 nm, using an Aminco-Bowman Series 2 spectrometer.
Fluorescence emission spectra, in the visible region (from 500 to 600 nm) were also recorded with excitation at 453 nm. CD spectra in the near-, far-UV and visible were recorded in a Jasco 710 spectropolarimeter. All experiments were carried out in darkness.
Thermal up-shift assay
Thermal denaturation was followed by recording FMN fluorescence emission (525 nm, with excitation at 453 nm) in an Aminco-Bowman Series 2 Spectrometer. Protein concentration was 10 µM in 10 mM phosphate buffer, pH 7.
Thermal denaturation curves were fitted to a two-state equation:
where S N and S U represent the spectroscopic signals of the native and unfolded states at 0 K, and m N and m U are the temperature dependences of those signals. The Gibbs energy function, ∆G(T), is given as:
with ∆C p and ∆H Tm being the unfolding heat capacity and enthalpy changes at T m , respectively. Fitting thermal unfolded curves to equation (1) 
where ∆H u and ∆Cp u are, respectively, the unfolding enthalpy and heat capacity changes at 
where ∆H T L is the binding enthalpy at the temperature T.
Dissociation Constants
Dissociation constants of the flavodoxin-ligand complexes were directly determined by titration, followed fluorometrically (excitation was at 464 nm, and the emission was 
where F is the observed fluorescence emission intensity of each solution, F p the emission of the protein, F c the emission of the complex, C p the total protein concentration, K d the dissociation constant of the complex in micromolar units, C L the total concentration of ligand in each solution, and B a constant (to fit the experimental final slope at high ligand concentrations). The robustness of the fits is indicated by the fact that the total concentration of protein, when treated as unknown, was correctly predicted (within 90%).
RESULTS AND DISCUSSION

Cloning, overexpression and purification
The H. pylori fldA gene was amplified using PCR. To design the oligonucleotides, the information available in the Genebank (EMBL) for H. pylori J99 strain was used. Two oligonucleotides, complementary to the beginning and to the end of the fldA gene, bearing
NcoI and BamHI restriction sites were synthesized. After amplification, a single band of approximately 600 nucleotides (Fig. 2 ) was identified.
The protein was purified to homogeneity from a bacterial extract using three anion exchange chromatography steps. Denaturant gel electrophoresis analysis revealed one major band with a molecular weight of 18 kDa (data not shown), which is in agreement with the expected value of 17.9 kDa.
Spectroscopic properties of H. pylori holoflavodoxin
Helicobacter pylori holoflavodoxin displays a characteristic absorbance spectrum in the visible (Fig. 3a) due to the bound FMN cofactor, with maxima at 378 nm and 452 nm. The near UV maximum is at 271 nm. The main near-ultraviolet and visible absorbance properties of H. pylori flavodoxin are compared to those of WT and W57A Anabaena flavodoxin in Table 1 . We noticed that mutation of the Anabaena W57 residue to alanine does not make the The far-UV CD spectrum of flavodoxin in 10 mM phosphate pH 7.0, is shown in Fig. 3d . The ellipticity minimum at 222 nm is consistent with a substantial amount of secondary structure, which is largely, but not completely, lost upon heating to 90 ºC. The spectrum is similar to that of the Anabaena flavodoxin where, in addition to secondary structure contributions, there are also contributions from aromatic residues. It should be noticed, in this respect, that the two proteins contain highly conserved clusters of aromatic residues.
The near-UV CD spectrum (Fig. 3e) shows distinct peaks, as is characteristic of a well-defined tertiary structure. The peaks are lost upon heating. This spectrum differs from that of Anabaena holoflavodoxin (unpublished) by having a very pronounced negative peak centred at 268 nm.
The visible CD spectrum ( The melting temperatures obtained from the thermal profiles were 317 K for H. pylori, 328 K for the Anabaena W57A mutant and 340 K for Anabaena WT flavodoxin. The stability rises in this series mimic the increase in the affinity of the three apoflavodoxin-FMN complexes, which for the Anabaena WT is around 3 kcalmol -1 higher than for the W57A mutant and 4 kcalmol -1 higher than for the H. pylori one (data not shown). This increase in complex stability is expected, because any ligand that specifically binds the native state of a protein should stabilize it [43] .
Small molecule Binding
The H. pylori flavodoxin crystal structure [24] is compared with the structure of the flavodoxin from the cyanobacteria Anabaena PCC7119 in Fig. 1a . (Fig. 5a ) is consistent with complex formation.
The binding seems to occur close to the FMN, as indicated by the quenching. Calculation of the dissociation constant by ligand titration gave a value around 4 kcalmol -1 for the benzylamine Anabaena W57A complex. When the binding of benzylamine to H. pylori flavodoxin was tested, we also found a marked quenching and the calculated binding of energy was around 3 kcalmol -1 (Table 3) .
To confirm benzylamine binding, we performed thermal up-shift assays. These assays As shown in Table 2 , thermal up-shift assays can detect ligand binding. Small and negative T m shifts are detected for the wild type Anabaena holoflavodoxin that should be attributed either to binding to non native conformations or to effects exerted through modifying water structure. In contrast the thermal melting transition of H. pylori flavodoxin was increased by 5 degrees in the presence of 50 mM benzylamine, while in the Anabaena W57A mutant, the shift was only of 2 K.
The calculation of binding constants, from thermal denaturation data, is based on two assumptions: all transitions are two-state in character, and ligands bind only to the nature state with a 1:1 stoichiometry [41] . All the parameters needed to calculate dissociation constants at 298 K are taken from the fits of the unfolding curves. The ligand binding enthalpy is the only parameter not experimentally determined from thermal melting transitions. For a majority of ligand /protein binding enthalpy measurements reported in the literature, however, an average near to -10 kcalmol -1 to -15 kcalmol -1 has been observed [47] [48] . In the absence of any other information, we assume that -15 kcal.mol -1 can be used to make reasonable estimates of K T [42] .
No binding constant can be calculated for Anabaena WT because of the negative shift observed in the melting transition temperature. Binding energies obtained by thermal shift assays agree well with those obtained by direct equilibrium methods (as titration) when they are extrapolated to identical temperature (-3.8 kcalmol -1 and -3.9 kcalmol -1 , respectively) for Anabaena W57A (Table 3) . Nonetheless, for H. pylori there is some difference between the energies calculated by titration (-2.7 kcalmol -1 ) and by thermal denaturation (-4.2 kcalmol -1 ), posibly due to the uncertainty in the estimated enthalpy of ligand binding.
H. pylori flavodoxin as a new drug target
The genetic diversity of the H. pylori species is large. Simultaneous infection with multiple strains of H. pylori that can exchange genetic sequences is common [49] . The development of clinically manifest disease during chronic infection seems to result from complex and poorly understood interactions among a number of factors, including the susceptibility of the host and the virulence of the infecting strains [50] .
Triple therapy has been the most successful method for eradicating H. pylori (eradication rate of 80-90%). However, increasing metronidazole resistance has limited the expansion of this therapy [51] . The activation of metronidazole, inside the bacteria, is closely linked to the oxidation of pyruvate [52] and requires reduction of the nitro group of nitroimidazole to generate the entity that kills susceptible bacteria. In aerobic conditions, this reduction is mediated by the POR complex. Electrons liberated in the oxidation of pyruvate, are first transferred to flavodoxin, from where they can be delivered to metronidazole. The short-lived reaction products formed can react with DNA, causing strand breaking and subsequent cell death [53] .
The problem associated to metronidazole resistance could be avoided by focusing on new targets. One obvious possibility is to block H. pylori electron transfer reactions at the flavodoxin level. Ligand binding near the FMN flavodoxin cofactor could easily disrupt electron transfer either by altering the redox potentials or by impeding the recognition of the POR-complex (which most likely will take place near the FMN site). Since the surface exposed region of the cofactor binding site is small and highly conserved among the flavodoxins of different species and, additionally, it constitutes the binding site of partner flavodoxin proteins, we hope inhibitors designed to bind there should resist genetic variability. Our preliminary study indicates that it is not difficult to identify small molecules, such as benzylamine, which bind to the H. pylori pocket, and thus may constitute leads towards inhibiting flavodoxin function. As the affinity of these molecules may be low, known methods of redesigning ligands for higher affinity will be needed [45] . [19] C. Hatzifoti, Helicobacter pylori vaccine strategies -triggering a gut reaction, Trends. 
